SOPHiA GENETICS (SOPH) Cost of Revenue (2020 - 2026)

SOPHiA GENETICS has disclosed Cost of Revenue across 7 years of filings, most recently posting $8.2 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 36.28% year-over-year to $8.2 million; the TTM figure through Jun 2026 stood at $28.8 million (up 28.08% YoY), while the FY2025 annual figure was $25.2 million, up 18.64% from the prior year.
• Cost of Revenue came in at $8.2 million for Q2 2026 at SOPHiA GENETICS, up from $6.9 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $8.2 million in Q2 2026 to a low of $3.8 million in Q4 2022.
• Average Cost of Revenue over 5 years is $5.4 million, with a median of $5.2 million recorded in 2023.
• Year-over-year, Cost of Revenue dropped 8.62% in 2022 and soared 37.22% in 2023.
• Over 5 years, Cost of Revenue stood at $3.8 million in 2022, then soared by 37.22% to $5.1 million in 2023, then grew by 9.34% to $5.6 million in 2024, then increased by 24.58% to $7.0 million in 2025, then advanced by 17.59% to $8.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $8.2 million in Q2 2026, $6.9 million in Q1 2026, and $7.0 million in Q4 2025.